Loading clinical trials...
Loading clinical trials...
This is a phase I, open-label, fixed sequence design, drug-drug-interaction (DDI) study divided in 2 parts. Part I is designed to evaluate whether concomitant treatment with linaprazan glurate and cla...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cinclus Pharma Holding AB
NCT07508241 · Obesity, Overweight and/or Obesity, and more
NCT07052162 · Pharmacokinetics of Tafenoquine
NCT07248826 · Herb-drug Interactions
NCT04961593 · Pharmacokinetics, Infection, Fungal
NCT06159699 · Risk Factors, Polypharmacy, and more
CTC Clinical Trials Consultants AB
Uppsala
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions